A randomized, double-blind, parallel-group, analog classroom study, evaluating Adderall XR [SLI-381] [extended release] versus Strattera [atomoxetine], dosed once daily, in children aged 6-12 with attention deficit hyperactivity disorder (ADHD)

Trial Profile

A randomized, double-blind, parallel-group, analog classroom study, evaluating Adderall XR [SLI-381] [extended release] versus Strattera [atomoxetine], dosed once daily, in children aged 6-12 with attention deficit hyperactivity disorder (ADHD)

Completed
Phase of Trial: Phase IV

Latest Information Update: 18 Aug 2007

At a glance

  • Drugs Atomoxetine; Mixed amfetamine salts
  • Indications Attention-deficit hyperactivity disorder
  • Focus Therapeutic Use
  • Sponsors Shire
  • Most Recent Events

    • 18 Aug 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top